WHO Launches Free Global Online Course to Improve Clinical Trial Quality and Ethical Research Standards

WHO says the initiative is part of a broader effort to strengthen global research systems, improve public trust in science, and support countries in preparing for future public health emergencies.

The World Health Organization (WHO) has launched a new free online training course aimed at strengthening the quality, ethics, and effectiveness of clinical trials worldwide, particularly in developing countries and regions with limited research capacity.

The new course, titled "WHO Good Practices for Clinical Trial Design and Implementation," is available through the WHO Academy online learning platform and is designed to help researchers, health professionals, policymakers, ethics committees, and clinical trial teams improve the planning and conduct of medical research.

WHO says the initiative is part of a broader effort to strengthen global research systems, improve public trust in science, and support countries in preparing for future public health emergencies.

Strengthening Clinical Trial Standards Worldwide

According to WHO, high-quality clinical trials are essential for producing reliable scientific evidence that informs health policy, clinical practice, and public confidence in medical innovation.

The organization noted that poorly designed or poorly conducted trials can undermine patient safety, delay scientific progress, and weaken trust in healthcare systems.

The new course translates WHO's 2024 "Guidance for Best Practices for Clinical Trials" into practical, applied learning that can be used across different countries, health systems, and disease areas.

The course was developed in response to requests from WHO Member States seeking stronger support for clinical research capacity and better preparedness for health emergencies.

WHO said the initiative also aligns with commitments outlined in World Health Assembly Resolution WHA75.8, which called for strengthening clinical trial coordination, quality, and equity globally.

WHO Emphasizes Importance of Trustworthy Science

Dr Sylvie Briand, WHO Chief Scientist, highlighted the importance of strong clinical trial standards in protecting participants and ensuring confidence in scientific research.

"Well-designed and well-conducted clinical trials are fundamental to protecting participants, producing trustworthy evidence and strengthening confidence in science," Briand said.

She explained that the course aims to provide a shared understanding of good clinical trial practices among a wide range of stakeholders involved in medical research.

According to WHO, improving trial quality is particularly important at a time when misinformation, scientific skepticism, and global health challenges are increasing pressure on healthcare systems and research institutions.

Clinical Trials Extend Beyond Medicines

WHO emphasized that clinical trials are not limited to testing pharmaceutical drugs.

Clinical trials can involve:

• Healthy volunteers

• Patients living with diseases

• Communities participating in public health interventions

The trials may assess a wide range of health-related interventions, including:

• Vaccines

• Medical devices

• Surgical procedures

• Diagnostic technologies

• Nutritional interventions

• Physical therapy treatments

• Psychological support programmes

• Digital health tools

• Traditional and herbal remedies

• Process-of-care improvements

The organization stressed that high-quality trials are essential for ensuring these interventions are safe, effective, and appropriate for public health use.

Recent Health Advances Highlight Importance of Clinical Trials

WHO pointed to several recent global health breakthroughs made possible through strong clinical research systems.

These include advances in:

• Long-acting HIV prevention injectables

• Innovative cancer therapies

• Malaria prevention and treatment

• Tuberculosis diagnostic tools

The organization noted that such medical advances demonstrate how ethical and scientifically rigorous clinical trials can directly improve global health outcomes and save lives.

"At a time when the global health agenda, and even science itself, is under attack, the importance of clinical trials cannot be overstated," said Dr Meg Doherty, Director of WHO's Science for Health Department.

She reaffirmed WHO's commitment to supporting the global research community, particularly in low- and middle-income countries where research infrastructure may still be developing.

Focus on Ethics, Participant Protection and Real-World Challenges

The self-paced online course is structured around five core scientific and ethical principles outlined in WHO's 2024 guidance.

Across nine interactive modules, learners explore how these principles can be applied in practical settings involving different diseases, populations, and healthcare systems.

The course takes approximately 4.5 hours to complete and focuses heavily on real-world decision-making.

Topics covered include:

• Ethical trial design

• Participant protection

• Informed consent

• Community engagement

• Operational feasibility

• Trial oversight

• Public health relevance

• Research coordination

• Ethical review processes

WHO said the course aims to help participants address common operational and ethical challenges that arise during clinical research implementation.

The organization also emphasized the importance of ensuring that clinical trials are participant-centred and responsive to public health priorities.

Interactive Learning and Global Accessibility

Early participants praised the course for combining practical guidance with interactive learning tools and real-world examples.

Dr Rajeshree Sanyal from The George Institute for Global Health in India described the programme as highly practical and engaging.

"The real-world case studies and interactive course format makes the learning process both engaging and easy to follow," she said.

Similarly, Mithun Mohan George from Sunnybrook Research Institute in Canada said the course successfully bridges the gap between ethical theory and operational realities in clinical research.

"The course successfully bridges the gap between ethical theory and operational reality, giving me the professional edge to ensure our trials are both robust and participant-centred," he explained.

He added that he had already started applying lessons from the course in his own research monitoring plans.

Expanding Access to Clinical Trial Education

WHO said one of the major goals of the initiative is to reduce barriers to high-quality clinical research education globally.

By making the course freely available online, the organization hopes to support countries in building sustainable research capacity that aligns with national and international health priorities.

Although the course is currently available only in English, WHO confirmed that additional language versions are planned in the coming years to improve global accessibility.

The organization believes expanding access to clinical trial education is especially important for low- and middle-income countries that are seeking to strengthen local research ecosystems and increase participation in international clinical research.

Supporting Future Pandemic Preparedness

The launch also reflects lessons learned from recent global health emergencies, including the COVID-19 pandemic, which highlighted both the importance and challenges of conducting rapid, ethical, and scientifically rigorous clinical trials during crises.

WHO says stronger clinical trial systems can improve preparedness for future outbreaks by enabling faster generation of reliable evidence for vaccines, treatments, and public health interventions.

The organization hopes the new course will contribute to stronger global collaboration, more equitable research participation, and improved health outcomes worldwide.

As countries continue investing in scientific capacity and healthcare resilience, WHO's new initiative is expected to play an important role in promoting ethical, inclusive, and high-quality clinical research across the global health community.